Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie K Jones

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
ACS Chemical Neuroscience|January 13, 2015
A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbancesMichael T Nedelcovych, Robert W Gould, Xiaoyan Zhan, et al.
ACS Medicinal Chemistry Letters|February 14, 2024
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 AgonistsNavoda Jayakodiarachchi, Mallory A Maurer, Daniel C Schultz, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffoldRichard Williams, Jason T Manka, Alice L Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 28, 2018
Muscarinic M<sub>5</sub> receptors modulate ethanol seeking in ratsAlice E Berizzi, Christina J Perry, David M Shackleford, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Molecular Psychiatry|March 16, 2025
Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndromeFederica Giona, Stefania Beretta, Antonio Zippo, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatinsThomas M Bridges, Joy E Marlo, Colleen M Niswender, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2016
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in SchizophreniaDarrick T Balu, Yan Li, Shunsuke Takagi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
ACS Chemical Neuroscience|January 13, 2015
A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbancesMichael T Nedelcovych, Robert W Gould, Xiaoyan Zhan, et al.
ACS Medicinal Chemistry Letters|February 14, 2024
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 AgonistsNavoda Jayakodiarachchi, Mallory A Maurer, Daniel C Schultz, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffoldRichard Williams, Jason T Manka, Alice L Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 28, 2018
Muscarinic M<sub>5</sub> receptors modulate ethanol seeking in ratsAlice E Berizzi, Christina J Perry, David M Shackleford, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Molecular Psychiatry|March 16, 2025
Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndromeFederica Giona, Stefania Beretta, Antonio Zippo, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatinsThomas M Bridges, Joy E Marlo, Colleen M Niswender, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2016
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in SchizophreniaDarrick T Balu, Yan Li, Shunsuke Takagi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Pageof 16